Health Care/Hospital Global News & Press Release Distribution

Health Care/Hospital

All
APAC

RoboPharma Acquired by Capsa Healthcare to Broaden Reach Into New Pharmacy Automation Markets

WAALWIJK, Netherlands, Aug. 26, 2020 /PRNewswire/ -- RoboPharma announced today the company has been acquired by Capsa Healthcare, a worldwide innovator in healthcare delivery solutions for hospitals, senior care settings, and retail pharmacy providers. Becoming an integral segment within Capsa H...

2020-08-26 08:12 2506

United Safety Introduces New Product to Deliver Active Air Purification Technology to Mass Transit

Device neutralizes airborne pollutants such as bacteria, mold, and viruses, including COVID-19. EXTON, Pennsylvania, Aug. 25, 2020 /PRNewswire/ -- United Safety & Survivability Corporation (formerly USSC Group) announced today that the company is ramping up availability of an innovative product...

2020-08-26 01:28 2281

ExoCoBio Inc. raises $9.3M in Pre-IPO Financing

* Its exosome-based regenerative aesthetics business is fast growing. * The IPO process will be initiated and stock trading is expected in 1Q 2021 on KOSDAQ. SEOUL, South Korea, Aug. 25, 2020 /PRNewswire/ -- ExoCoBio Inc. announced that it recently raised$9.3 million in its series C and Pre-IP...

2020-08-25 22:00 3101

ExoCoBio Inc. raises $9.3M in Pre-IPO Financing

The Brain Protection Company Awarded $1M Research Grant To Pursue Novel Approach To Treat Alzheimer's Disease

SYDNEY, Aug. 25, 2020 /PRNewswire/ -- The Brain Protection Company Pty Ltd, a privately-held medical device company developing novel therapies and diagnostics for Alzheimer's disease, today announced it has been awarded aUS$1 million grant from the Part the Cloud – Bill Gates Partnership Grant Pr...

2020-08-25 13:31 2078

The Brain Protection Company Awarded $1M Research Grant To Pursue Novel Approach To Treat Alzheimer's Disease

CureApp Named to the 2020 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

NEW YORK, Aug. 24, 2020 /PRNewswire/ -- CB Insights today named CureApp to its second annualDigital Health 150 ranking, which showcases the 150 most promising private digital healt...

2020-08-24 20:16 2159

WPI-MANA Team: New Solid Materials Enable Broader Application of Medical Gases

TSUKUBA, Japan, Aug. 24, 2020 /PRNewswire/ -- Hydrogen sulfide (H2S) and nitric oxide (NO) are gases with useful bio-activities, such as anti-oxidation, anti-inflammation and vasodilation. H2S is an ingredient in hot springs and long known to have positive effects on the skin and cardiovascular s...

2020-08-24 14:00 1584

Adlai Nortye Announces First Patient Dosed in Phase 1b Clinical Trial of AN0025 (EP4 Antagonist) in Combination with Merck's KEYTRUDA® (pembrolizumab) for Advanced Solid Tumors

NORTH BRUNSWICK, N.J., Aug. 24, 2020 /PRNewswire/ -- Adlai Nortye Ltd. ("Adlai Nortye"), a global clinical-stage biopharmaceutical company today announced that the first patient has been dosed in a phase1b clinical trial (AN0025S0103) to evaluate AN0025, an investigational, potentially first in c...

2020-08-24 13:13 1534

South Korea's KT Develops AI-Based COVID-19 Research

SEOUL, South Korea, Aug. 20, 2020 /PRNewswire/ -- KT Corp. (KRX: 030200; NYSE: KT),South Korea's largest telecommunications company, is developing a COVID-19 infection risk assessment model, using its artificial intelligence (AI) and Big Data-based digital contact tracing technology, adding to gl...

2020-08-20 21:00 8727

CARsgen Therapeutics Receives IND Clearance from the NMPA for CT041 CLDN18.2-CAR-T Cells

SHANGHAI, Aug. 20, 2020 /PRNewswire/ -- CARsgen Therapeutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that the National Medical Products Administration (NMPA) has cleared its Investigational New Drug (IND) application for the first-in-class drug candidate CT041, auto...

2020-08-20 18:32 4447

111, Inc. Announces Second Quarter 2020 Unaudited Financial Results

SHANGHAI, Aug. 20, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a company dedicated to digitally connecting patients with drugs and healthcare services inChina, today announced its unaudited financial results for the second quarter endedJune 30, 2020. Second Quarter 2020...

2020-08-20 16:35 11598

111, Inc. Announces New Capital Injection and Strategic Plan to Expand Access to China's Capital Markets

* Completion of new capital injection in principal subsidiary Yao Fang Shanghai * Initiation to list shares of principal subsidiary Yao Fang Shanghai on the STAR Market * 111 firmly committed to maintaining Nasdaq listing status SHANGHAI, Aug. 20, 2020 /PRNewswire/ -- 111, Inc. ("111" or th...

2020-08-20 16:30 9552

PharmAbcine announces the execution of a Material Cooperative Research and Development Agreement (MCRADA) with the NIH to evaluate the efficacy of PMC-403 to treat SCLS

DAEJEON, South Korea, Aug. 18, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a Materials Cooperative Research and Development Agreement (MCRADA) with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), in whic...

2020-08-18 21:00 8679

Global Cord Blood Corporation to Report First Quarter Fiscal 2021 Financial Results

HONG KONG, Aug. 18, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results fo...

2020-08-18 19:00 3932

Koichiro Matsumoto Appointed President/CEO of Bushu Pharmaceuticals Ltd.

KAWAGOE, Japan, Aug. 18, 2020 /PRNewswire/ -- In response to requests for a professional contract development and manufacturing organization (CDMO) partner inAsia that can better meet the needs and challenges of the global market, Bushu Pharmaceuticals Ltd. (hereinafter "Bushu Pharma") appointed ...

2020-08-18 14:00 1788

China Biologic Reports Financial Results for the Second Quarter of 2020

BEIJING, Aug. 17, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the second quarter of 2020. Second Quart...

2020-08-18 04:30 9974

I-Mab Announces First Patient Dosed in Phase 1b Study of Plonmarlimab in Rheumatoid Arthritis in China

SHANGHAI and GAITHERSBERG, Md., Aug. 17, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first patient has been dosed with plonmarlimab ...

2020-08-17 20:00 3606

CARsgen Announces the Publication of a Novel CAR-T Technology that Improves the Efficacy of CAR-T cells Against Solid Tumors without Requiring Preconditioned Lymphodepletion

SHANGHAI, Aug. 17, 2020 /PRNewswire/ -- CARsgen Therapeutics, a leader in developing novel CAR-T cell therapies against solid tumors, today announced its publication of the 7×21 CAR-T technology in CLINICAL CANCER RESEARCH. The article is titled "Coexpression of IL-7 and CCL21 increases efficacy ...

2020-08-17 18:00 4147

China Jo-Jo Drugstores Reports First Quarter 2021 Financial Results

HANGZHOU, China, Aug. 14, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its fina...

2020-08-14 21:00 8035

China Pharma Holdings, Inc. Reports Second Quarter 2020 Financial Results

HAIKOU CITY, China, Aug. 14, 2020 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the qu...

2020-08-14 18:30 5997

Bushu Pharmaceuticals Announces Major Expansion Program

KAWAGOE, Japan, Aug. 14, 2020 /PRNewswire/ -- - Japan's Premier CDMO Will Invest $100m to Expand Capacity and Portfolio - Bushu Pharmaceuticals Ltd., one of Japan's largest contract manufacturers of pharmaceutical products, announced onAugust 14 a major capital program costing $100 million to ex...

2020-08-14 14:00 2621

1 ... 254 255 256257258 259 260 ... 282